Drug Shortage Report for TEVA-HALOPERIDOL

Last updated on 2023-05-23 History
Report ID 167177
Drug Identification Number 00363669
Brand name TEVA-HALOPERIDOL
Common or Proper name HALOPERIDOL
Company Name TEVA CANADA LIMITED
Market Status MARKETED
Active Ingredient(s) HALOPERIDOL
Strength(s) 2MG
Dosage form(s) TABLET
Route of administration ORAL ORAL
Packaging size 100
ATC code N05AD
ATC description ANTIPSYCHOTICS
Reason for shortage Disruption of the manufacture of the drug.
Anticipated start date
Actual start date 2022-08-18
Estimated end date 2023-02-28
Actual end date 2023-04-17
Shortage status Resolved
Updated date 2023-05-23
Company comments
Health Canada comments
Tier 3 Status No
Contact Address 30 NOVOPHARM COURT
TORONTO, ONTARIO
CANADA M1B 2K9
Company contact information

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v10 2023-05-23 English Compare
v9 2023-04-18 English Compare
v8 2023-04-17 French Compare
v7 2023-04-17 English Compare
v6 2022-12-01 French Compare
v5 2022-12-01 English Compare
v4 2022-11-15 English Compare
v3 2022-10-17 French Compare
v2 2022-10-17 English Compare
v1 2022-08-18 English Compare

Showing 1 to 10 of 10